Tag: misleading claims

  • Delhi High Court Orders Patanjali to Pause Negative Ads Targeting Dabur

    Delhi High Court Orders Patanjali to Pause Negative Ads Targeting Dabur

    MUMBAI: The rivalry between India’s leading Ayurvedic brands entered the legal arena this week, as the Delhi High Court ordered Patanjali Ayurved to halt all advertisements disparaging Dabur’s chyawanprash. The directive reflects the judiciary’s increasing scrutiny of advertising claims in the high-stakes wellness sector.

    The dispute began after Dabur, one of India’s oldest and most established names in Ayurvedic health, alleged that Patanjali’s recent campaigns not only targeted its flagship product, but also implied
    that competitors use inferior or artificial ingredients—claims Dabur described as misleading and potentially damaging to consumer trust.

    In its preliminary order, the court noted that while comparative advertising is allowed, it cannot cross into unfair or baseless disparagement. The judges observed that advertising should inform, not
    mislead, and must avoid statements that unjustly tarnish the reputation of rival products.

    The interim order requires Patanjali to suspend all negative advertisements against Dabur chyawanprash until further notice. The case will proceed for detailed examination of the ad content and
    industry standards.

    The legal intervention underscores the fierce marketing competition in India’s booming Ayurvedic and natural health market, where trust and authenticity are prized by both brands and consumers. Industry experts say the ruling sends a clear signal to marketers: fair play remains essential in the fight for health-conscious buyers.

    The matter is scheduled for further hearing in the coming weeks, when the court will assess the factual basis of Patanjali’s claims and address the broader issue of responsible advertising in the wellness
    sector. For now, both companies—and the wider industry—are watching closely, aware that the outcome could set the tone for brand battles in India’s fast-growing consumer market.

    (If you are an Anime fan and love Anime like Demon Slayer, Spy X Family, Hunter X Hunter, Tokyo Revengers, Dan Da Dan and Slime, Buy your favourite Anime merchandise on AnimeOriginals.com.)
     

  • Patanjali Ayurved apologises to SC over misleading ads

    Patanjali Ayurved apologises to SC over misleading ads

    MUMBAI: So, finally, India’s leading Ayurveda flagbearer has Patanjali Ayurved has bent its knees. The firm has issued an “unqualified apology” to India’s supreme court  about its stance of issuing misleading advertisements and criticism  modern medicines. It has assured the court that it will put a full stop to issuing such ads. 

    The apex court had on 19 March ordered the Swami Ramdevi Acharya Balkrishna owned Patanjali Ayurved to appear before it to clarify the failure to respond to the contempt notice, and misleading advertisements about medicinal cures.

    The supreme court had earlier reprimanded the company from issuing false ads and the counsel for the company had on 21 November 2023 assured it that “henceforth there shall not be any violation of any law(s), especially relating to advertising or branding of products manufactured and marketed by it and, further, that no casual statements claiming medicinal efficacy or against any system of medicine will be released to the media in any form.”

    But Patanjali Ayurved had continued to do so unafraid which led to the court rapping it hard on its knuckles on 27 February banning it from issuing ads for medicines with misleading claims. It had also slapped the central government on its wrists for “sitting with eyes closed” while the entire country was “taken for a ride.”

    The apex court had issued contempt of court notices against both Swami Ramdev and Acharya Balkrishna citing flouting of previous court orders by continuing to peddle misleading claims.